“It doesn’t take an expert to say why a company that has earned US$45 billion from pneumonia vaccine sales…doesn’t need a subsidy to sell at lower prices” - the AC’s Ananth Ganesan @ganesan_ananth on Gavi’s failure to support more affordable vacci...